Moreover, in a recent study of 103 patients, 19 had LRRK2 mutations, 20 GBA mutations and 64 were non-carriers PD patients; no significant differences in motor outcomes were found between the studied groups, as well. Here, LRRK2 is linked to Parkinson disease.